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Understanding the mechanism of re-entrant arrhythmias in the past 30 years has allowed
the development of almost curative therapies for many rhythm disturbances.The complex,
polymorphic arrhythmias of atrial fibrillation (AF) and sudden death are, unfortunately, not
yet well understood, and hence still in need of adequate therapy. AF contributes markedly to
morbidity and mortality in aging Western populations. In the past decade, many genetically
altered murine models have been described and characterized. Here, we review genetically
altered murine models of AF; powerful tools that will enable a better understanding of the
mechanisms of AF and the assessment of novel therapeutic interventions.
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INTRODUCTION
Atrial fibrillation (AF) affects 1–2% of the population in Europe,
and this number is expected to increase twofold to threefold in the
next decade, due to both an age-dependent increase in AF and an
increased incidence of the arrhythmia (Camm et al., 2010). Even
when treated according to best current knowledge, AF remains
associated with high residual morbidity and an excess mortality
(Camm et al., 2010) that calls for better understanding, diagnosis,
and therapy of the arrhythmia rather than the management of
symptoms alone. The considered use of animal models has facil-
itated the characterization of at least four positive feedback loops
that contribute to the development of AF (Schotten et al., 2011).
Two of these loops augment Ca2+ loading and alter ion channel
dynamics, which result in the shortening of atrial action potential
duration (APD) and focal ectopic activity. Both can be treated with
anti-arrhythmic drugs and catheter ablation (Kirchhof et al., 2009)
and these techniques can help prevent AF recurrence in selected
patients, but the overall recurrence rate of AF remains high.
Unfortunately, some patients with AF are predisposed to recur-
rent arrhythmias even on such therapy. The changes that pre-
dispose the atria toward recurrence of AF have been broadly
summarized as “structural remodeling”. Better characterization
of these processes are required to enable the identification of
patients at risk of recurrence and to develop new therapies for
the arrhythmia (Schotten et al., 2011; Wakili et al., 2011).
OF MICE AND MEN
There is no doubt that the best model in which to study human
disease mechanisms is the patient. However, many of the mol-
ecular changes that confer AF are more pronounced in left atrial
tissue (Kahr et al., 2011), which is not readily accessible in patients.
Furthermore, the polygenic and multi-factorial processes that gov-
ern AF render genetically modified models attractive tools in
which to dissect the molecular mechanisms of arrhythmia. Models
facilitate the control of confounding factors, enable demonstra-
tion of causation rather than association and offer opportunities
to validate new therapies in an experimental setting. In recent
years, owing to its small size, short gestation period, rapid matu-
ration, and the relative ease with which genetic alterations can
be achieved, the mouse has become an attractive mammalian
model in which to investigate a number of human conditions.
Inbred murine models reduce genetic and environmental vari-
ability, enabling disease progression and the effect of genetic mod-
ifiers including gender, diet, and physical activity on pathology,
to be studied in a closed, complex physiological system. His-
torically, cardiac arrhythmias were studied in larger mammals
such as the goat, pig, or dog, as it was believed that arrhythmia
did not occur in mice due to their lack of critical cardiac mass
(Janse and Rosen, 2006). Furthermore, the hearts of larger mam-
mals such as non-human primates and dogs are more akin to
the human heart than rabbits or smaller rodent species (Russell
and Proctor, 2006). However, the seminal and relatively recent
demonstrations, disproving the theory of critical cardiac mass
(Vaidya et al., 1999), have promoted the use of mice in the study
of cardiac arrhythmias. There is considerable genetic homology
between humans and mice and this is reflected in the conserva-
tion of cardiac developmental pathways, morphological structure,
and signaling pathways. There are however, inevitable differences
between the murine and human heart: the murine heart rate
is up to 10 times faster than that of the human heart and the
murine APD is shorter and lacks the typical plateau phase (Fab-
ritz et al., 2003). Yet the relationship between electrical diastole
and APD in the mouse is comparable with that of humans. In
summary, whilst the mouse provides an excellent model system
for primary investigation, molecular underpinnings, and proof of
principle strategies, all findings need to be confirmed in other
animal models and in vitro systems prior to considering clinical
application.
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MURINE MODELS OF ATRIAL FIBRILLATION
In terms of cardiac assessment, the pipelines of large-scale phe-
notyping consortia are usually limited to the analysis of blood
chemistry, the assessment of heart weight relative to tibial length
and the assessment of left ventricular function which, whilst good
indicators of cardiac dysfunction, will no doubt often fail to
identify an arrhythmic phenotype. Electrocardiograms (ECGs) in
lightly sedated and freely roaming mice can be used to diagnose
atrial arrhythmias. To study electrophysiological mechanisms of
atrial arrhythmias, the use of isolated,beating,perfused hearts have
been invaluable. These can be subjected to catheter-based record-
ing of electrograms and action potentials; to electrical stimulation
and other arrhythmia provocation techniques, and can be used in
conjunction with optical mapping to visualize membrane poten-
tial and calcium transients (Eloff et al., 2001; Mathur et al., 2009).
These techniques, first developed to study ventricular arrhythmias
in mice, have more recently been adapted to study atrial arrhyth-
mias as well (de Diego et al., 2008; Lang et al., 2011). There has
been a recent increase in the number of murine models reported
to harbor atrial arrhythmias, some of which have been reviewed
before (Schotten et al., 2011; Wakili et al., 2011). In this review,
murine models were grouped according to the molecular signal-
ing pathway with which they have been most associated as follows:
alterations in: G-protein coupled receptor (GPCR) signaling; ion
channel dynamics, anchoring, and junctional complexes, calcium
homeostasis; transcriptional, post transcriptional, and epigenetic
regulation; cytokines and growth factors. In this review we have
provided a simplified schematic depicting the position of these
murine models both within the context of previously established
molecular signaling pathways of atrial arrhythmia and subcellu-
lar compartment (Figure 1). We have also generated a tabulated
list of murine models in which AF or a surrogate parameter was
reported (Table 1). The table indicates whether structural atrial
changes were found and gives an idea of whether AF occurred
spontaneously under free roaming conditions, under anesthesia,
or was provoked during programmed stimulation.
In the following text we will highlight several of these models
to exemplify the complex and divergent changes that can result in
FIGURE 1 | Murine Models of Atrial Fibrillation. Schematic diagram
depicting murine models of atrial arrhythmia within the context of
arrhythmic signaling pathway and subcellular localization. Models were
subdivided into altered G-Protein Coupled Receptor signaling; altered
ion channels dynamics, anchoring, and junctional complexes; altered
calcium homeostasis; altered transcriptional, post transcriptional, and
epigenetic regulators; and cytokines and growth factors. The genotype
of knockout models associated with atrial fibrillation is provided;
knockin models are followed by the suffix (KI), and transgenic models
by the suffix (Tg). A brief description of each model, the experimental
circumstances used to elicit AF and references can be found within
Table 1.
Frontiers in Physiology | Cardiac Electrophysiology August 2012 | Volume 3 | Article 296 | 2































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































www.frontiersin.org August 2012 | Volume 3 | Article 296 | 3










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Frontiers in Physiology | Cardiac Electrophysiology August 2012 | Volume 3 | Article 296 | 4



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































www.frontiersin.org August 2012 | Volume 3 | Article 296 | 5
Riley et al. Mouse models of AF
murine AF. We hope that understanding mechanisms of arrhyth-
mia in such models will further our understanding and treatment
of AF in humans.
MODELS OF AF WITH ALTERED G-PROTEIN COUPLED
RECEPTOR SIGNALING
Systemically, GPCRs are involved in extracellular-intracellular sig-
naling and underpin a wide variety of biological responses (Neer,
1994; Park et al., 2004). The most commonly studied GPCRs
in the heart include the adrenergic, angiotensin, endothelin, and
adenosine receptors (Salazar et al., 2007).
ANGIOTENSIN II
The role of renin-angiotensin signaling within cardiac patholog-
ical states, particularly in regard to blood pressure, is well doc-
umented. However, there is increasing evidence that angiotensin
II exerts a more local stimulatory effect on heart function (San-
cho et al., 1976; Lindpaintner et al., 1988; De Mello and Frohlich,
2011). Furthermore, atrial angiotensin II expression levels are
increased in patients with AF (Boldt et al., 2003; Cong et al., 2010;
De Jong et al., 2011). In vitro, rapid pacing of atrial myocytes
increased the paracrine secretion of angiotensin II (Tsai et al.,
2011), suggesting that fibrillation promotes angiotensin II produc-
tion and therefore signaling. Cardiac-specific overexpression of
angiotensin I converting enzyme (ACE), a peptidase that converts
angiotensin I to its biologically active counterpart, angiotensin II,
in mice, resulted in atrial dilation, fibrosis, and spontaneous AF
under free roaming conditions (Xiao et al., 2004), suggesting that
increased angiotensin II signaling promotes the development of
AF. Yet, cardiac-specific overexpression of the angiotensin receptor
AT1a caused marked atrial enlargement, bradycardia, and abnor-
mal atrio-ventricular (AV) conduction, but failed to increase AF
susceptibility in neonatal mice (Hein et al., 1997).
ADENOSINE RECEPTORS
Adenosine receptors are a type of purinergic G-Protein coupled
receptor, activated by adenosine, that have an inhibitory effect on
adenlyl cyclase signaling (and therefore cAMP levels) and voltage-
gated ion channels, whilst concomitantly activating potassium
channels (Priori et al., 1993; Headrick et al., 2011). Short-term
adenosine A1 receptor (A1AR) stimulation induces bradycardia
and AV block in humans (DiMarco et al., 1983). Transgenic mod-
els of adenosine A1 and A3 receptors were developed primarily
to evaluate the protective effect of receptor overexpression on
myocardial ischemia (Matherne et al., 1997). However, enhanced
expression of either A1 or A3 adenosine receptors also provoked
atrial bradycardia and AV block and increased susceptibility to AF
dependent on the degree of bradycardia (“tachycardia-bradycardia
syndrome”; Kirchhof et al., 2003; Fabritz et al., 2004), that could
potentially lead to bradycardiomyopathy (Fabritz et al., 2004).
Therefore, increased cAMP levels (as shown by this model and that
of ACE overexpression) appear to contribute to the development
of AF.
GALPHA Q
Heterotrimeric G-proteins are membrane-associated complexes
that comprise an alpha, beta, and gamma subunit and are the intra-
cellular effectors of GPCRs (Neer, 1994; Park et al., 2004; Salazar
et al., 2007). In the heart, Gαq associates with alpha1-adrenergic,
endothelin (ETA), and angiotensin II type I (AT1) receptors. Fol-
lowing ligand activation, Gαq is phosphorylated which results
in the activation of numerous downstream effectors including
phospholipase C (PLC), protein kinase C (PKC), thymoma viral
protein-oncogene (Akt), and Ras homologous (Rho; Salazar et al.,
2007; Filtz et al., 2009; Ben-Ami et al., 2011; Pfreimer et al., 2012).
To investigate the putative role of Gαq in cardiac hypertrophy, two
transgenic mouse lines overexpressing endogenous and a constitu-
tively active Gαq subunit under the control of the αMhc promoter
were independently generated (D’Angelo et al., 1997; Mende et al.,
1998). Both models developed cardiac hypertrophy in the absence
of myocyte disarray or necrosis, followed by diffuse atrial and ven-
tricular fibrosis and heart failure (D’Angelo et al., 1997; Mende
et al., 1998; Hirose et al., 2009). A number of these mice developed
left atrial thrombi, another pathological characteristic associated
with AF (Mende et al., 1998; Laakmann et al., 2010), and indeed,AF
was recorded as occurring spontaneously under roaming condi-
tions (Hirose et al., 2009). Similar to the Ras homolog gene family
member A (RhoA) overexpression model discussed below, there is
recent evidence to suggest that in this model, AF may be a primary
pathology within its own right that does not occur secondary to
ventricular remodeling (Sah et al., 1999; Laakmann et al., 2010).
RAS HOMOLOG GENE FAMILY MEMBER A
Initially identified for its role within hypertrophic signaling path-
ways (Sah et al., 1996), RHOA is a small membrane-associated
GTPase involved in actin cytoskeleton organization (Ridley and
Hall, 1992). Mice overexpressing either wild type RHOA or an
activated form of RHOA under the control of the cardiac-specific
αMhc promoter died prematurely and developed cardiac enlarge-
ment, cellular hypertrophy, interstitial fibrosis, and heart failure
(Sah et al., 1999). Atrial enlargement was more pronounced than
ventricular enlargement, suggesting atrial dilation preceded ven-
tricular dilation, which is consistent with the reported tempo-
ral cardiac expression profile of αMhc (Chizzonite et al., 1982;
Sweeney et al., 1985; Bouvagnet et al., 1987; Colbert et al.,
1997). Electrocardiography (ECG) performed under anesthesia
was indicative of AF and AV block (Sah et al., 1999).
More recently overexpression of RhoGDIα, an endogenous spe-
cific GDP dissociation inhibitor for all Rho family proteins, led to
atrial arrhythmias and mild ventricular hypertrophy (Wei et al.,
2004). ECG and intracardiac electrophysiological analysis showed
these mice developed bradycardia, AV block, and atrial arrhyth-
mias concomitant with reduced expression of the gap junction
protein, connexin 40, before the onset of cardiac hypertrophy and
heart failure (Wei et al., 2004). Taken together these murine mod-
els suggest that altered expression levels of Rho family proteins can
propagate a pro-arrhythmic environment.
Rac1
Rat sarcoma (RAS)-related C3 botulinum toxin substrate 1 (Rac1)
has long been recognized for its role in actin cytoskeleton organi-
zation, and is a plasma membrane-associated GTPase belonging to
the RAS superfamily (Ridley and Hall, 1992; Sussman et al., 2000).
Homozygous mice overexpressing constitutively active Rac1 under
the control of the αMhc promoter were found to be viable
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(Chizzonite et al., 1982). However, a proportion of progeny died
within 2 weeks of birth owing to increased postnatal αMhc pro-
moter activity as a result of increased circulating levels of thyroid
hormone (Chizzonite et al., 1982; Sussman et al., 2000). Mice sur-
viving this initial vulnerable period achieved survival comparable
with that of wild type (Sussman et al., 2000), but by 2 months of
age, mutants developed atrial enlargement and atrial wall thinning
juxtaposed to ventricular wall thickening and reduced ventricular
chamber size (Sussman et al., 2000). Interstitial fibrosis and systolic
heart failure progressively developed and 75% of the transgenic
mice developed spontaneous AF under anesthesia (Adam et al.,
2007).
OTHER MODELS OF ALTERED GPCR SIGNALING
Several other murine models of AF have been generated by the
genetic manipulation of other proteins within GPCR signaling
cascades using αMhc promoter-driven expression. Briefly, mod-
els reported to develop spontaneous AF under anesthesia include
a knockout of serine/threonine kinase 11 (Stk11/Lkb1; Bardeesy
et al., 2002; Ikeda et al., 2009; Pretorius et al., 2009); a trans-
genic mouse overexpressing Muscle-Related Coiled-Coil protein
(MURC1; Ogata et al., 2008) and a transgenic mouse overex-
pressing human protein kinase AMP-activated gamma 2 subunit
(PRKAG2) carrying the N488I mutation (Arad et al., 2003). A dou-
ble transgenic mutant overexpressing dominant negative phos-
phatidyl inositol 3 kinase and macrophage stimulating 1 (Mst1)
was also reported to develop spontaneous AF during telemetry
(Pretorius et al., 2009).
MODELS OF AF WITH ALTERED ION CHANNEL DYNAMICS,




Potassium ion channels remove K+ from the cell defining the
repolarization phase of the action potential. Therefore, any genetic
modification that alters the expression levels or gating of potas-
sium channels has the potential to alter the cardiac action potential
and thereby act as an arrhythmic substrate. Models include: the
systemic knockout of the small conductance calcium-activated
potassium channel (SK2) which increased susceptibility to AF
induction (Bond et al., 2004; Li et al., 2009), and the systemic
knockout of the voltage-gated subfamily E member 1 potas-
sium channel (KCNE1) which resulted in spontaneous AF under
telemetry (Kupershmidt et al., 1999; Temple et al., 2005).
Sodium channels
SCN5A. Sodium currents are responsible for the rapid depolar-
ization of myocytes and are important for conduction, repolariza-
tion, and refractoriness. Similar to potassium channel disruption,
several animal models in which sodium channel dynamics have
been altered develop AF. SCN5A encodes the alpha subunit of
the cardiac voltage-gated sodium channel (Nav1.5; Gellens et al.,
1992). Mutations within SCN5A underlie a number of clinically
defined arrhythmias including long QT syndrome type 3 (LQT3),
Brugada syndrome, progressive conduction disease, and AF (Ruan
et al., 2010; Wilde and Brugada, 2011) and many of these diseases
harbor a propensity for atrial arrhythmias (Eckardt et al., 2001;
Zellerhoff et al., 2009).
Systemic targeted disruption of Scn5a results in homozygous
lethality whilst heterozygotes display a 50% reduction in sodium
conductance (Papadatos et al., 2002). A knockin murine model,
Scn5a ∆1505-1507 KPQ (∆KPQ-Scn5a), of a human mutation
in which three amino acids within the inactivation domain of
Nav1.5 were deleted, resulted in a persistent inward Na+ cur-
rent thus delaying the repolarization of the action potential and
causing longer QT intervals (Wang et al., 1996; Nuyens et al.,
2001; Head et al., 2005). ECG recorded by telemetry and under
anesthesia revealed that heterozygous mice mimic the long QT
syndrome 3 phenotype found in patients (Nuyens et al., 2001).
More recently, atrial electrophysiology was assessed in ∆KPQ-
Scn5a mutant mice. Concurrent with ventricular action potentials,
atrial action potentials were also prolonged (Dautova et al., 2009;
Blana et al., 2010). ∆KPQ-Scn5a mice were more susceptible to
atrial arrhythmias induced by maneuvers known to provoke tor-
sades de pointes, namely short-long-short stimulation sequences
(Blana et al., 2010). Aged ∆KPQ-Scn5a mice were reported to be
more susceptible to atrial arrhythmias induced by programmed
stimulation (Guzadhur et al., 2010), and have altered sinoatrial
node function and intra-atrial conduction (Head et al., 2005; Wu
et al., 2012).
Analysis of another knockin murine model, homozygous for
the human D1275N mutation (Groenewegen et al., 2003; Remme
et al., 2006), reported slowed conduction, atrial arrhythmias, sinus
node dysfunction, and progressive AV block, that culminated in
sudden death at around 12 weeks of age (Watanabe et al., 2011).
Mutations within other accessory subunits of the cardiac sodium
channel also affect channel dynamics; homozygous deletion of the
beta subunit, SCN3B, led to conduction disturbances, bradycar-
dia, and an increased susceptibility to induced atrial arrhythmias
(Hakim et al., 2008, 2010; Olesen et al., 2011).
ANCHORING AND JUNCTIONAL COMPLEXES
Connexins
The cardiac voltage sodium channel, Nav1.5, was shown to colo-
calize with Connexin 43 within the intercalated disk of ventricular
cardiomyocytes (Maier et al., 2002). The gap junction proteins
Connexin 40 (Cx40, GJA5) and Connexin 43 (Cx43, GJA1) func-
tion to electrically couple cardiomyocytes, facilitating syncytial
contraction. Cx40 and Cx43 are expressed at equal levels in atria
however, only Cx43 is expressed in the ventricles (Lin et al., 2010).
Both mutations in CX40 and CX43 have been reported in patients
with idiopathic AF (Gollob et al., 2006; Thibodeau et al., 2010).
Cardiac-specific loss of Cx43 and overexpression of a dominant
negative mutant of Cx43 led to the development of spontaneous
ventricular arrhythmias (Hong et al., 2008; Sood et al., 2008; Li
et al., 2012), consistent with a predominating ventricular role in
the mouse. However, systemic loss of Cx40 (or GJA5) in the mouse
resulted in an increased propensity to induced atrial arrhythmias
and reduced conduction velocity (Kirchhoff et al., 1998; Hagen-
dorff et al., 1999;Verheule, 1999). Furthermore, loss/redistribution
of Cx40 appears to be a common feature of other murine models
of AF including overexpression of RHOA, overexpression of con-
stitutively active RAC1, cardiac-specific overexpression of ACE,
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overexpression of Tumor necrosis factor (TNF), and cardiac over-
expression of cAMP Response element modulator (CREM; Sah
et al., 1999; Kasi et al., 2007; Sawaya et al., 2007; Adam et al., 2010;
Kirchhof et al., 2011a; see Table 1 and Figure 1 for further details).
Recent evidence suggests that in the heart of higher vertebrates,
the protein complexes that traditionally comprise the cell–cell
junctions of the adherens junctions and desmosomes of epithelial
cells, actually coordinate to form a single heterogeneous junction
referred to as the area composita (Borrmann et al., 2006; Franke
et al., 2006). Loss of desmin, an intermediate filament that selec-
tively associates with desmosomal complexes, has been reported to
lead to atrial fibrosis and increased susceptibility to AF induction
(Li et al., 1996; Milner et al., 1996; Schrickel et al., 2010). Hence,
disrupted cell–cell mechanical coupling may also act as a substrate
for AF.
Ankyrin B
The ankyrin family are membrane-associated adaptor pro-
teins that serve to link membrane-associated proteins with the
cytoskeleton (Bennett and Gilligan, 1993; Li et al., 1993). Loss of
function of Ankyrin B (ANK2) is associated with long QT syn-
drome and sudden cardiac death in humans and mice (Mohler
et al., 2003). Previously, ankyrin B was shown to regulate cardiac
sodium channels dynamics (Chauhan et al., 2000), Na/K ATPase,
Na/Ca exchanger 1, and inositol triphosphate (InsP3; Mohler et al.,
2005). Loss of ankyrin B was reported to increase cardiac Na+
channel opening times, increasing APD (Chauhan et al., 2000).
Recent evidence suggests that disrupted ankyrin B function is a
predisposing factor for the development of atrial arrhythmias in
humans (Cunha et al., 2011). Mice heterozygous for ankyrin B
were reported to develop spontaneous atrial arrhythmias under
telemetry and ECG studies showed increased susceptibility to
AF induction by pacing (Cunha et al., 2011). In the same work,
ankyrin B was shown to bind to the alpha 1C subunit of the L-type
Ca2+ channel (Cav1.2) and loss of ankyrin B resulted in reduced
inward Ca2+ current and a shortened APD (Cunha et al., 2011).
Hence, it would appear that ankyrin B regulates both Na+ and
Ca2+ currents and that disruption of ankyrin B perturbed these
currents and lead to spontaneous AF.
CALCIUM HOMEOSTASIS
The voltage-dependent L-type Ca2+ channel contributes to the
late depolarizing currents of the cardiac action potential. Com-
prising five subunits in total, the alpha subunit of the L-type Ca2+
channel is the transmembrane spanning subunit. In the heart,
the alpha 1d subunit (Cav1.3) is exclusively expressed in the atria
(Zhang et al., 2005), where it plays an important role in the spon-
taneous diastolic depolarization of pacemaker cells (Zhang et al.,
2002a). Systemic deletion of Cav1.3 rendered mice susceptible to
AF induction (Zhang et al., 2005; Mancarella et al., 2008).
Calcium homeostasis is important in the maintenance of nor-
mal sinus rhythm and contraction: Ca2+ induced Ca2+ release
is the mainstay of mechanoelectrical coupling, clearance of Ca2+
from the cytosol significantly contributes to the late depolarizing
currents of the cardiac action potential and Ca2+ acts as a sec-
ondary messenger within many intracellular signaling pathways.
Therefore, any genetic modification that alters the expression levels
or gating of calcium channels; or modifies signaling cascades in
which Ca2+ features as a secondary messenger, has the potential to
act as an arrhythmogenic substrate. Previous reviews of AF mod-
els have focused on calcium homeostasis therefore, we will only
mention them briefly (Schotten et al., 2011; Wakili et al., 2011).
Murine models with mutations in the ryanodine receptor and
associated proteins are reported to be susceptible to AF (see
Table 1). Models include: mice carrying the human mutation,
R176Q, within the outward Ca2+ channel of the sarcoplasmic
reticulum, ryanodine receptor 2 (RyR2; Chelu et al., 2009); mice
carrying the human mutation, P2328S, within RyR2 (Goddard
et al., 2008; Zhang et al., 2011); systemic deletion of the RyR2
binding protein, FKBP12.6 (Wehrens et al., 2003; Sood et al., 2008;
Li et al., 2012); cardiac-specific overexpression of the Ca2+ binding
protein, junctate 1 (Hong et al., 2002, 2008); cardiac-specific over-
expression of the sarcoplasmic transmembrane protein, junctin
(Hong et al., 2002; Kirchhof et al., 2007), and systemic deletion
of the Ca2+- and GTP-dependent membrane-associated protein,
annexin Aa7 (Anxa7; Herr et al., 2001; Schrickel et al., 2007). Of
note, spontaneous AF was observed in mice with a 29-fold over-
expression of junctin, whereas mice with 10-fold overexpression
showed only reduced adaption of heart rate to stress (Hong et al.,
2002; Kirchhof et al., 2007).
Sarcolipin (SLN) is a transmembrane protein located within the
sarcoplasmic reticulum that like phospholamban, is a key regulator
of sarcoplasmic reticulum Ca2+ ATPase (SERCA) function (Oder-
matt et al., 1998; Asahi et al., 2003; Minamisawa et al., 2003; Babu
et al., 2007a; Bhupathy et al., 2009). However, unlike phospholam-
ban, SLN activity is mediated by calcium-calmodulin dependent
protein kinase II (CaMKII), not protein kinase A (PKA; Bhupathy
et al., 2009). At low Ca2+ concentrations, SLN inhibits SERCA,
reducing its affinity for Ca2+ which has the effect of slowing
Ca2+ uptake into the sarcoplasmic reticulum, reducing contrac-
tility (reduced force generation and speed of relaxation; Tupling
et al., 2002). Reduced levels of SLN mRNA and protein expression
are associated with chronic AF in humans (Uemura et al., 2004;
Shanmugam et al., 2011). Aged homozygous SLN knockout mice
(Babu et al., 2007b) were reported to develop atrial fibrosis and
spontaneous AF under anesthesia (Xie et al., 2012), suggesting that
increased SERCA function promotes AF.
MODELS OF AF WITH ALTERED TRANSCRIPTIONAL, POST
TRANSCRIPTIONAL, AND EPIGENETIC REGULATION
Dysregulation of GPCR signaling, ion channel dynamics, and cal-
cium homeostasis have long been associated with the development
and maintenance of AF however, the net effect of these path-
ways upon transcription and the contribution of transcriptional,
post transcriptional, and epigenetic dysregulation to AF are less
well understood. This represents a rapidly expanding area of AF
research and it is here, within this category, the majority of the
more recently described animal models of AF reside.
cAMP RESPONSE ELEMENT MODULATOR
cAMP Response element modulator belongs to the cAMP response
element binding (CREB)/activating transcription factors (ATF)
family of transcription factors and is a phosphorylation target of
PKA. Cardiac-directed expression of CREM-Ib∆C-X, a human
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cardiac CREM repressor isoform, resulted in both atrial and ven-
tricular enlargement, atrial wall thinning, atrial thrombus forma-
tion, disturbed myocyte architecture, and increased basal left ven-
tricular function (Müller et al., 2005). Echocardiography analysis
revealed that atrial chamber dilation preceded the development
of AF (Kirchhof et al., 2011a). In addition to reduced wall thick-
ness, atrial myocytes were elongated and atrial weight increased,
while neither cellular hypertrophy nor fibrosis were found (Kirch-
hof et al., 2011a). Telemetric ECG indicated that mutants suffered
from atrial ectopies, the occurrence of which increased with age
until mice entered an almost constant state of atrial tachycardia
(Kirchhof et al., 2011a). Reduced phosphorylation of CREM (due
to overexpression of CREM-Ib∆C-X) was associated with altered
Ca2+ homeostasis concurrent with spontaneous Ca2+ release and
reduced gap junction protein expression (CX40; Kirchhof et al.,
2011a). CREM transcription factors bind to the cAMP response
element found within several promoters (Foulkes et al., 1991).
Whilst many of the genetic targets of CREM involved in spermato-
genesis have been identified (Kosir et al., 2012), cardiac-specific
gene targets remain largely unknown and are subject to current
studies.
PITX2c
The paired-like homeodomain transcription factor 2 (Pitx2) is
a downstream target of Nodal within the transforming growth
factor beta (TGFβ) signaling pathway and was primarily recog-
nized as having a role in establishing left-right asymmetry during
embryonic development (Meno et al., 1998; Ryan et al., 1998). The
highest Pitx2 isoform expressed in the murine and human heart
is Pitx2c (Kitamura et al., 1999; Schweickert et al., 2000). Systemic
loss of Pitx2c in mice lead to embryonic lethality and resulted in a
number of phenotypes including abnormal cardiac morphogene-
sis (Gage et al., 1999). During embryogenesis, Pitx2c was shown to
synergistically drive expression of natriuretic peptide A (Nppa) in
the presence of the homeobox transcription factor, Nkx2.5 (Ganga
et al., 2003) which in turn, suppressed the expression of the pace-
maker channel gene, Hcn4, and the T-box transcription factor
(Tbx3), gene, thus delineating contractile atrial myocardium from
the sinoatrial node (Hoogaars et al., 2007; Mommersteeg et al.,
2007).
Genome-wide association studies (GWAS) identified sequence
variation within 4q25 as conferring increased susceptibility to AF
(Schott et al., 1995; Gudbjartsson et al., 2007; Kääb et al., 2009).
Hence, owing to its genomic location within this candidate region,
PITX2 was considered a prime candidate gene for the development
of atrial arrhythmias in man. Indeed, expression analysis con-
firmed that PITX2C was also expressed in adult left atrial tissue,
further supporting a biological function beyond that of embryonic
left-right patterning (Wang et al., 2010; Kirchhof et al., 2011b). In
mice carrying a hypomorphic allele of Pitx2c, sedation and pacing
revealed an increased tendency of atrial flutter and tachycardia in
heterozygous mutants (Wang et al., 2010). Isolated, beating hearts
carrying a heterozygous Pitx2c-deletion had a reduced APD and
were also susceptible to AF (Kirchhof et al., 2011b). Echocardio-
graphy suggested there were no apparent morphological defects
(Kirchhof et al., 2011b). In contrast, homozygous deletion of
Pitx2c in the heart, appeared to provoke structural changes later
in life as well as changes in ion channel expression (Chinchilla
et al., 2011), which could also offer mechanistic insight into the
observed arrhythmic phenotype.
Given its role in suppressing “pacemaker” genes and defining
the contractile myocardium, it has been proposed that loss of
Pitx2c results in a“less left”atrial phenotype promoting ectopic left
atrial activity however, how this is achieved in fully differentiated,
adult myocardium is unclear at present.
T-BOX TRANSCRIPTION FACTOR 3
Similar to loss of Pitx2c, mice over expressing Tbx3, another gene
implicated in the specification of pacemaker cells, in a cardiac-
specific manner, developed atrial ectopic beats (Hoogaars et al.,
2007).
RTEF-1
Transcription enhancer factor-1-related factor (RTEF-1) is a tran-
scriptional target of alpha1-adrenergic signaling (Stewart et al.,
1998; Ueyama et al., 2000). Cardiac-specific overexpression of
human RTEF-1 in mice led to the development of spontaneous
AF under telemetry, an increased tendency to AF induction by
burst pacing in younger mice and the development of sustained
AF in older (12 months) transgenic founder mice (Chen et al.,
2004). Atrial dilation and thrombi were reported in this trans-
genic model however, there was no evidence of fibrosis. Owing to
reduced atrial conduction velocity, the expression levels of phos-
phorylated compared to dephosphorylated Cx40 were assessed:
The levels of phosphorylated Cx40 were found to be reduced con-
comitant with an increase in dephosphorylated Cx40 suggesting
that gap junction complexes were compromised in this model of
AF (Chen et al., 2004).
JUN DIMERIZATION PROTEIN 2
c-Jun dimerization protein 2 (JDP2) is a transcriptional repressor
belonging to the basic leucine zipper (bZIP) family of transcrip-
tion factors (Aronheim et al., 1997; Jin et al., 2001). Tetracycline-
regulated cardiac-specific overexpression of JDP2 resulted in atrial
dilatation and atrial myocyte hypertrophy and reduced conduc-
tion velocity (Kehat et al., 2006). Furthermore, spontaneous AF
under anesthesia was reported in a “small number” of mice (Kehat
et al., 2006). Cx40 protein levels were also perturbed in this model
(reduced expression level of total Cx40), which was indicative of
the inhibitory effect of JDP2 on Cx40 promoter activity (Kehat
et al., 2006). Hence loss of Cx40 may also be an attributing factor
to the observed conduction defects and the development of AF in
this model.
NUCLEOPORIN 155
Nucleoporin 155 (NUP155) is a major component of the nuclear
pore complex within the nuclear envelope that facilitates the trans-
port of DNA and mRNA from the nucleus to the cytoplasm
(Zhang et al., 2002b). Systemic heterozygous deletion of NUP155
in mice, reportedly lead to spontaneous AF under roaming condi-
tions (Zhang et al., 2008). More importantly, a single nucleotide
polymorphism that evokes a missense mutation within NUP155
has been identified as contributing to AF in patients (Zhang
et al., 2008). In vitro analysis showed that this mutation impaired
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nuclear permeability to Nup155 gene products (Zhang et al., 2008).
NUP155 was recently shown to interact with histone deacetylase
4 (HDAC4), hence this arrhythmic phenotype may also be the
consequence of altered transcriptional activity (Kehat et al., 2011).
MICRORNAs
In recent years a number of microRNAs (miRNA), endogenous
non-coding∼22mer RNA molecules that regulate gene expression
by gene silencing, have been increasingly implicated in cardiac
pathology (Wakili et al., 2011; Wang et al., 2011). This high-
lights the potential role of post transcriptional regulation along-
side other such control mechanisms as transcriptional regulation,
translational regulation, and post-translational modification.
miR-328
miR-223, miR-328, and miR-664 were found to be upregulated
in a canine model of AF (Yue et al., 1997; Lu et al., 2010). The
generation of a transgenic mouse overexpressing miR-328 under
the control of the αMhc promoter, resulted in the development
of spontaneous AF under anesthesia (Lu et al., 2010). Further-
more loss of miR-328 protected against AF induction via pacing
following muscarinic acetylcholine receptor stimulation (Lu et al.,
2010). The alpha 1c and beta 1 subunits of the L-type Ca2+ chan-
nel were identified as targets of miR-328, and the expression levels
of the L-type Ca2+ channel protein subunits encoded by these
genes, Cav1.2 and Cavβ1, were also reduced, suggesting that the
observed shorter APD in this model is the result of reduced L-type
Ca2+ currents (Lu et al., 2010).
miR-208
Transgenic mice overexpressing miR-208a displayed reduced car-
diac function by 3 months of age and went on to develop first and
second degree AV block (Callis et al., 2009). Conversely, loss of
miR-208a in a murine knockout model had a protective effect
on cardiac remodeling following thoracic aortic banding (van
Rooij et al., 2007). Despite the seemingly positive effect of reduc-
ing miR-208a on cardiac pathology, miR-208a knockout mice also
developed spontaneous AF under anesthesia (Callis et al., 2009).
The effect of miR-208b on cardiac conduction has yet to be inves-
tigated but it differed from miR-208a by only 3 bp and shared
identical seed regions (Callis et al., 2009), hence it seems likely
that miR-208b regulates the same targets as miR-208a (Callis et al.,
2009) and that both feature within arrhythmogenic signaling path-
ways. miR-208a and miR-208b are encoded within intron 27 of the
αMhc and βMhc genes respectively (van Rooij et al., 2007) and reg-
ulatory targets of miR-208a include thyroid hormone associated
protein 1 and myostatin (see next paragraph; Callis et al., 2009).
CYTOKINES AND GROWTH FACTORS
MYOSTATIN
Myostatin was among the first proteins to be identified as a neg-
ative regulator of hypertrophy (McPherron et al., 1997). Very
recently, cardiac-specific expression of the inhibitory N-terminus
of myostatin pro-peptide was shown to increase susceptibility to
AF induction in mice (Rosenberg et al., 2012). Taken together,
these results suggest that loss of myostatin expression can act
as a substrate for AF. Preliminary data has shown the voltage-
gated potassium channel Kv1.4 (KCNA4) to be upregulated in
this model, although the impact of this on APD has yet to be
determined (Callis et al., 2009; Rosenberg et al., 2012).
TRANSFORMING GROWTH FACTOR BETA 1
Transforming growth factor beta 1 (TGFß1) is a cytokine that
regulates numerous cellular processes including growth, differ-
entiation, adhesion, migration, and apoptosis. However, in the
adult heart, TGFß1 is a key regulator of fibrosis. Enhanced fibrosis
reduces the electrical coupling of cardiomyocytes (Shaw and Rudy,
1997; Allessie et al., 2005). The atria have been shown to be more
susceptible to fibrotic remodeling (Burstein et al., 2008) and pacing
of cultured atrial-derived myocytes was shown to increase expres-
sion of TGFβ1 (Yeh et al., 2011). In patients, increased expression
levels of TGFß1 are associated with chronic AF, valvular heart dis-
ease, atherosclerosis, and pressure overload (Lamirault et al., 2006;
Xu et al., 2010; Creemers and Pinto, 2011). In mice, cardiac-specific
overexpression of constitutively active TGFß1 caused atrial fibro-
sis, atrial conduction disturbances, and AF (Verheule et al., 2004).
Recent data suggested that triggered activity arising due to reduced
APD and spontaneous Ca2+ release, contribute to the develop-
ment of AF in this murine model (Choi et al., 2012). Increased
levels of angiotensin II and reactive oxygen species were shown to
increase the promoter activity of Tgfβ1, connective tissue growth
factor (Ctgf), and collagen in fibroblasts thus perpetuating a profi-
brotic environment that could promote conduction defects (Hao
et al., 2011; Tsai et al., 2011).
TUMOR NECROSIS FACTOR
Tumor necrosis factor (formerly referred to as TNFα) is another
inflammatory cytokine implicated in the development and pathol-
ogy of AF in humans (Cao et al., 2011; Deng et al., 2011). Cardiac-
specific overexpression of TNFα in mice resulted in atrial dilation,
fibrosis, thrombi development, and spontaneous AF under roam-
ing conditions (Kubota et al., 1997; Saba et al., 2005). In a second
TNF overexpression model, downregulation of the gap junction
protein Connexin 40 was also reported (Sawaya et al., 2007).
CONCLUSION
A long list of murine models that confer increased susceptibility
to atrial arrhythmias, further substantiates the value of geneti-
cally altered murine models in advancing our understanding of
the processes that initiate and propagate AF. In this review, mod-
els were grouped into signaling pathways already associated with
AF. However, this is not to say that the proteins they encode
are restricted to any single pathway. Each “pathway” most likely
represents a small component of a much larger, more complex,
pro-arrhythmic pathway.
In the vast majority of models, atrial arrhythmia was reported
to be induced in a non-physiological setting such as anesthesia
or pacing (more than three quarters of mouse mutants reported
in Table 1). The relationship between anesthesia and AF is still
of clinical relevance (Laakmann et al., 2010). However pacing
induced arrhythmia suggests that whilst there is a substrate for
atrial arrhythmia, this can be well tolerated and undetected in the
absence of a triggering factor. Reported cases of spontaneous atrial
arrhythmias in freely roaming mice were relatively rare (less than
a quarter of the mouse mutants reported in Table 1) and almost
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always accompanied by atrial enlargement and/or fibrosis. We were
intrigued to find that the majority of models reported to develop
spontaneous AF without anesthesia or interventions were trans-
genic overexpression mutants. High levels of overexpression may
have a toxic effect on the cell that also contributes to atrial pheno-
type, whereby overexpression leads to structural changes beyond
those observed during “normal” pathophysiology. It is also possi-
ble that such expression levels may actually trigger a common final
pathological pathway that mimics human pathology. Indeed the
majority of the mutant models discussed in this review displayed
dose dependent phenotypes that arose due to the heterozygous or
homozygous expression and/or the positional effect of transgene
integration (D’Angelo et al., 1997; Mende et al., 1998; Sussman
et al., 2000; Fabritz et al., 2004; Kasi et al., 2007). The differential
onset of αMhc promoter expression during embryogenesis in the
atria and at birth in the ventricles (Chizzonite et al., 1982; Sweeney
et al., 1985; Bouvagnet et al., 1987; Colbert et al., 1997; Hein et al.,
1997; Wei et al., 2004) might also mitigate a gene dosage effect
across the heart.
Atrial fibrillation is a complex arrhythmia, and is likely to
depend on multiple intertwined mechanisms. While the principal
dysregulations in ion channel function and intracellular calcium
homeostasis have been characterized, more recent genetic findings
suggest that dysregulation of gene transcription and an imbalance
in major regulatory pathways of cell function may contribute to
the complex genesis of AF. Future challenges include the identifi-
cation and investigation of the downstream components of these
pathways and henceforth, the identification of therapeutic targets.
The use of GWAS will lead to the development of new models
of AF that better mimic human pathology from a different per-
spective. The differences between man and mice notwithstanding,
murine models offer unique opportunities to investigate the func-
tional and biochemical consequences of such complex regulatory
changes, and to integrate these domains into our understanding
of the genesis of AF.
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